Article · 2015
Editorial Board Member
Ghazaleh Shoja E Razavi
Director of Clinical and Medical Affairs, Director of Clinical and Medical Affairs, Global Allied Pharmaceuticals, USA
About
As published by the journal they serve.
Ghazaleh Shoja E Razavi, MD, Ph.D. is a clinical hematologist /oncologist with a shining track record in practicing medicine and clinical research. Ghazaleh was trained in Internal medicine and board certification in Hematology, Medical Oncology. She is trained in supportive and palliative care in cancer patients in Italy granted by European Society for Medical Oncology (ESMO). She has mostly focused on targeted therapies in oncology, especially basic and clinical aspects of immunotherapy in both solid tumors and hematologic malignancies. She has been mentoring and guiding leaders of biopharmaceutical industries in clinical trials, safety, and in line with their drug approval process for 4 years. She is also an attending physician for the past 6 years in training fellows of Hematology and Oncology. She is an accomplished MD, a guiding mentor to fellow practitioner, and a strong leader in clinical research and drug development.
Research interests
Journals they serve
The seats these journals name them in.
- Brain Disorders & TherapyEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2018
Competitive Treatment in Diffuse Large B-cell lymphoma (DLBCL) and the Future SOC for the First Line Therapy
Article · 2016
Cancer Treatment in the Checkpoint Inhibitor Era
Article · 2015
Emerging Role of Interleukins in Cancer Treatment
Article · 2015
Htlv1 Associated Myelopathy, Its Diagnosis, Management and Complications
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
